Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients
Cristina Diaz-Perdigones, Araceli Muñoz‐Garach, Maria D. Alvarez-Bermudez, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112448-112448
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 326
Understanding the action mechanisms of metformin in the gastrointestinal tract
Meihui Cheng, Lili Ren, Xianxian Jia, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16
Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 302-302
Open Access | Times Cited: 16
Mechanism of metformin regulation in central nervous system: Progression and future perspectives
Gui Cao, Ting Gong, Yue Du, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113686-113686
Open Access | Times Cited: 54
Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus
Lina He, Rongping Chen, Bangzhou Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects
Ana K. Carrizales-Sánchez, Oscar Tamez‐Rivera, Nora A. Rodríguez-Gutiérrez, et al.
BMC Pediatrics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 8
Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes
Yoscelina Estrella Martínez-López, Daniel Neri-Rosario, Diego Esquivel-Hernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, et al.
(2024)
Open Access | Times Cited: 6
Selective impact of three homogenous polysaccharides with different structural characteristics from Grifola frondosa on human gut microbial composition and the structure-activity relationship
Guangjian Bai, Yizhen Xie, Xiong Gao, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 132143-132143
Closed Access | Times Cited: 6
Potato Resistant Starch Type 1 Promotes Obesity Linked with Modified Gut Microbiota in High-Fat Diet-Fed Mice
W. B. Zhang, Nana Zhang, Xinxin Guo, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 370-370
Open Access | Times Cited: 5
Effects of the Lipid Profile, Type 2 Diabetes and Medication on the Metabolic Syndrome—Associated Gut Microbiome
Grațiela Grădișteanu Pîrcălăbioru, Janie Liaw, Ozan Gundogdu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7509-7509
Open Access | Times Cited: 21
Integrating 16S rDNA and metabolomics to uncover the therapeutic mechanism of electroacupuncture in type 2 diabetic rats
Yue Zhang, Xiang Wang, Deng Duping, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
The therapeutic success of approaches to the gastrointestinal microbiome modulation in the treatment of obesity, metabolic syndrome and type 2 diabetes mellitus
Anastasia A. Zabolotneva, О. П. Шатова, J. A. Agapova, et al.
Diabetes Mellitus (2025) Vol. 27, Iss. 6, pp. 598-610
Open Access
Preparation technologies, structural characteristics and biological activities of polysaccharides from bee pollen: A review
Wangting Zhou, Yuzhen He, Jimin Lv, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141545-141545
Closed Access
Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?
Angela Horvath, Kristina Žukauskaitė, Olha Hazia, et al.
Endocrinology Diabetes & Metabolism (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Colonic epithelial hypoxia remains constant during the progression of diabetes in male UC Davis type 2 diabetes mellitus rats
Brian D. Piccolo, James L. Graham, Leslie Tabor‐Simecka, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 2, pp. e003813-e003813
Open Access | Times Cited: 2
Analyzing the gut microbiota and microbial-associated metabolites of tomato-based sauces
Alicia Paulina Cárdenas-Castro, Mônica Maurer Sost, Wilbert Gutiérrez-Sarmiento, et al.
Food Chemistry (2024) Vol. 460, pp. 140664-140664
Closed Access | Times Cited: 2
Almond (Prunus dulcis) Bagasse as a Source of Bioactive Compounds with Antioxidant Properties: An In Vitro Assessment
Stevens Duarte, Almudena Mateu Puchades, Nuria Jiménez‐Hernández, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1229-1229
Open Access | Times Cited: 6
Direct self-assembly of AIE-active tetraphenylethene derivative with cucurbit[7]uril as a fluorescence probe for metformin detection
Chenrui Jiang, Geyuan Li, Yue Chen, et al.
Microchemical Journal (2023) Vol. 191, pp. 108830-108830
Closed Access | Times Cited: 5
Enhancing Metformin Effects by Adding Gut Microbiota Modulators to Ameliorate the Metabolic Status of Obese, Insulin-Resistant Hosts
Elena Maria Seicaru, Ioana Ilie, Adrian Cătinean, et al.
Journal of Gastrointestinal and Liver Diseases (2022) Vol. 31, Iss. 3, pp. 344-354
Open Access | Times Cited: 8
Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational Program
Laura Molteni, Giuseppe Marelli, G Castagna, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 12, pp. 1422-1430
Open Access | Times Cited: 1
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR Signaling Pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Authorea (Authorea) (2024)
Open Access | Times Cited: 1
Microbiota Transplantation in Individuals with Type 2 Diabetes and a High Degree of Insulin Resistance
Ana María Gómez Pérez, Araceli Muñoz‐Garach, Agustín Lasserrot-Cuadrado, et al.
Nutrients (2024) Vol. 16, Iss. 20, pp. 3491-3491
Open Access | Times Cited: 1
Single-cell hemoprotein (heme-SCP) exerts the prebiotic potential to establish a healthy gut microbiota in small pet dogs
Seungki Lee, Ahyoung Choi, Kyung-Hoon Park, et al.
Food Science and Biotechnology (2022) Vol. 32, Iss. 4, pp. 489-496
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top